HIV/AIDS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. HIV antibody tests positive by Western Blot confirmation; 2. HAART treatment time for 1 year or more; 3. CD4+ T lymphocyte counts between 200-350 cells/mm3; 4. HIV-RNA<40 copies/ml; 5. All genders, Aged 18-65 years; 6. Voluntary participation in this study was signed by informed consent.
Exclusion criteria
Exclusion criteria: Conforming to inclusion criteria, but has one of the following conditions shall be excluded: 1. The one who suffers from severe opportunistic infections; 2. Patients who are participating in other treatment studies within 3 months; 3. Patients who are receiving immunomodulatory treatment within 3 months; 4. Patients who are complicating with other diseases, such as severe cardiovascular, renal diseases, tuberculosis, malignant tumors, severe organic heart disease, severe arrhythmia, abnormal liver function (AST and ALT increased more than 2 times), and immune diseases, etc.; 5. Patients who are Suffering from serious mental and neurological problems; 6. Pregnant or lactating women; 7. Patients who allergic to moxibustion, Chinese herbal medicine or adhesive tape; 8. Patients who are mentally or mentally disabled and fails to fully understand the content of the experiment or who can not cooperate well; 9. Other reasons cannot be treated on time; 10. The researchers believe other reasons which are not appropriate for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD4+, CD8+count;CD4CD45RA, RO;Th1, Th2;cytokine;Semeiology indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| HIV viral load; | — |
Countries
China
Contacts
Kunming Municipal Hospital of Traditonal Chinese Medcine